--- title: "SLN Stock 12‑Month Price Target Raised to $33.8, Implies 183% Upside" type: "News" locale: "en" url: "https://longbridge.com/en/news/295461234.md" description: "Silence Therapeutics Plc's average 12-month price target was raised to $33.8 by five analysts, up from $32.4, implying an 183% upside based on the Aug. 7 closing price. The consensus rating remains 'Buy' across seven covering analysts, with six buys and one sell." datetime: "2026-08-10T23:20:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295461234.md) - [en](https://longbridge.com/en/news/295461234.md) - [zh-HK](https://longbridge.com/zh-HK/news/295461234.md) generator: "portal-rs" --- # SLN Stock 12‑Month Price Target Raised to $33.8, Implies 183% Upside - According to estimates from 5 analysts, Silence Therapeutics Plc - American Depository Share stock's average price target has risen from $32.4 to $33.8, with forecasts ranging from $10 to $75 per share - Based on the Aug. 7 closing price, the updated target implies approximately 183% potential upside - Consensus rating remains at “Buy” across 7 covering analysts, with 6 Buys, 0 Holds and 1 Sells Explore more price target data and ratings for Silence Therapeutics Plc - American Depository Share on the , and track all previous and future analyst recommendations for Silence Therapeutics Plc - American Depository Share in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [SLN.US](https://longbridge.com/en/quote/SLN.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) ## Related News & Research - [Silence Therapeutics closes upsized $201.3 million ADS follow-on offering at $13.5 each](https://longbridge.com/en/news/295975817.md) - [Silence Therapeutics Announces Major ADS Public Offering](https://longbridge.com/en/news/295715727.md) - [Why SPS Commerce stock was a winner on Wednesday](https://longbridge.com/en/news/296413157.md) - [Estée Lauder forecasts FY27 organic sales growth of 3%-5%](https://longbridge.com/en/news/296372891.md) - [Scandinavian Investment Group H1 FY26 net profit rises to DKK 23 million; lifts FY26 net profit outlook to DKK 33 million-38 million](https://longbridge.com/en/news/296459205.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**